The Company designs, develops and markets innovative aesthetic medical products based on its ELOS, technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This former Rule Breaker has bounced back pretty well from our sell recommendation in 2009. It has a lot of cash (always did), so the underlying business isn't priced for much. I'll rejoin the fray on this one and give it another green thumb. Please note, this may be a contrary indicator: I struck out in my first at-bat with ELOS.